HbA and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Danne T, Sawhney S, Peters A, McGuire D, Lapuerta P, Kushner J, Franek E, Brath H, Brändle M, Banks P, Cariou B, Strumph P. HbA and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study. Diabetes care 2018; 41:1981-1990.
Jun 24, 2018
HbA and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Jun 24, 2018
Diabetes care 2018; 41:1981-1990
Danne Thomas, Sawhney Sangeeta, Peters Anne L, McGuire Darren K, Lapuerta Pablo, Kushner Jake A, Franek Edward, Brath Helmut, Brändle Michael, Banks Phillip, Cariou Bertrand, Strumph Paul
more